Picture an index chart that looks healthy. It closed the week at a new high, its 50-day moving average is rising, and the heaviest volume sessions of the month were…
Picture two growth companies that pass the same earnings screen in the same week. Both reported quarterly earnings per share up more than 40% for two straight quarters, both sit…
A growth stock has climbed from 42.00 to 68.50 in fourteen weeks, and then it stalls. For the next seven weeks the weekly bars drift sideways. Price never trades above…
Two research decks land in the same week. The first belongs to a manager who called four big macro turns over three years and got every one of them right.…
The band around the forecast is a claim you can test A forecasting model hands you two things at once. There's the number everyone reads, say a projected close of…
DQ is back on traders' screens this week, so it's worth pulling up the chart that mattered most. In the summer of 2020 the stock closed at 13.77 on 23…
A backtest can look flawless and still be untradeable. I've watched rules with clean equity curves that assumed every signal filled at the closing print fall apart the moment real…
You run a factor screen at the end of August, and the ten names at the top look familiar. You run it again four weeks later. The same companies are…
A backtest hands you a clean-looking number. The strategy's average edge is 0.4% a week, the confidence interval sits comfortably away from zero, and the significance test says a result…
Two accounts finish the year at the same value, built from the same set of returns. One you could have held without much stress. The other spent months trading below…